Company / Capital Expenditures
Steris Capital Expenditures History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$370.1M
FY2024
5-year range
$287.6M / $370.1M
FY2020-FY2024
Trend
+2.7%
vs FY2023
Sector context
#30 of 145
Health Care
What the data says
Steris's capital expenditures of $370M is higher than 79% of companies in the Health Care sector (FY2024). Improved from $362M to $370M over the past 2 years.
Based on SEC 10-K filings.
$370M in FY2024 with a 5-year CAGR of +11.5%. Top quartile in the Health Care sector.
Improved from $362M to $370M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 145This company $370.1M Sector average $268.6M
▼
+37.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.5%, indicating consistent growth.
- In FY2024, capital expenditures increased 2.7% year-over-year.
- Ranks #30 out of 145 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $370.1M | +2.7% |
| FY2023 | $360.3M | -0.5% |
| FY2022 | $362.0M | +25.9% |
| FY2021 | $287.6M | +20.2% |
| FY2020 | $239.3M | +11.5% |
| FY2019 | $214.5M | +13.1% |
| FY2018 | $189.7M | - |
| FY2017 | - | - |
| FY2016 | $172.9M | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026